Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tetra SiafiledCriticalTetra Sia
Priority claimed from PCT/LV2010/000007external-prioritypatent/WO2010151095A1/en
Publication of MX2011013750ApublicationCriticalpatent/MX2011013750A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
Novel betaine salts of acetylsalicylic acid, namely 4-trimethylammoniobutanoate acetylsalicylate (meldonium acetylsalicylate), Z-carnitine acetylsalicylate and 3- (trimethylammonioamino)-propanoate (meldonium) acetylsalicylate. Use of meldonium acetylsalicylate as antiplatelet agent for treating various pathologies induced by platelet aggregation, anti-inflammatory and antihyperlipidemic agent.
7-CYCLOPENTIL-2- (5-PIPERAZIN-1-IL-PYRIDIN-2-IL-AMINO) -7H-PIRROLO- [2,3-D] -PYRIMIDIN-6- ACID DIMETHYL-AMIDE SALT (S) CARBOXYL AND PROCESSES FOR ITS PREPARATION